The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Advanced Therapeutics Pharmaceutical Outsourcing Market From 2026 To 2030?
The advanced therapeutics pharmaceutical outsourcing market has shown consistent expansion in recent years. It is anticipated to grow from $8.41 billion in 2025 to $8.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.0%. This historical growth can be attributed to a rising biologics pipeline, the high costs of in-house manufacturing, an increasing prevalence of oncology and rare diseases, a lack of internal expertise in advanced therapies, and the globalization of clinical trials.
The advanced therapeutics pharmaceutical outsourcing market is projected to experience substantial expansion over the upcoming years. Its size is anticipated to reach $10.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period can be linked to factors such as the rising adoption of personalized medicine, the broadening of commercial-scale cell and gene therapies, heightened regulatory complexity, an increase in funding for biotech start-ups, and the need for quicker time-to-market. Key trends identified for the forecast period encompass an uptick in the outsourcing of cell and gene therapy manufacturing, an escalating demand for comprehensive CDMO services, the development of specialized viral vector production capabilities, an enhanced emphasis on regulatory and quality compliance assistance, and expedited clinical trial outsourcing for uncommon and intricate medical conditions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
What Major Drivers Are Influencing Demand In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market is projected to experience growth going forward, driven by the increasing integration of cell and gene therapies. These innovative treatments involve the use of living cells or genetic material to manage or eradicate diseases. Advanced therapeutics pharmaceutical outsourcing plays a crucial role in cell and gene therapies by enabling companies to partner with providers who have a proven track record and experienced personnel, which in turn saves significant time and resources compared to establishing in-house teams. For instance, in March 2024, IQVIA Holdings Inc., a US-based company offering advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries, reported that global expenditure on cell and gene therapies climbed to $5.9 billion in 2023, indicating a 38% increase from 2022. This upward trend in the adoption of cell and gene therapies is therefore a key factor driving the expansion of the advanced therapeutics pharmaceutical outsourcing market.
Which Segments Are Included In The Analysis Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Which Trends Are Impacting The Growth Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies engaged in the advanced therapeutics pharmaceutical outsourcing market are concentrating on strategic partnerships to offer dependable services to customers. A strategic partnership is a collaborative arrangement between two or more entities, typically businesses, established to achieve shared beneficial goals that each partner could not attain independently. For instance, in January 2023, Lonza, a Switzerland-based manufacturing company for the pharmaceutical, biotechnology, and nutrition sectors, formed a partnership with Context Therapeutics Inc., a US-based biopharmaceutical company advancing medicines for solid tumors. This collaboration involves Lonza providing manufacturability assessment, gene and cell line construction, and process development for both the drug substance and drug product.
Which Key Industry Participants Are Active In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics
Read the full advanced therapeutics pharmaceutical outsourcing market report here:
Which Region Shows The Strongest Potential For Future Growth In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Advanced Therapeutics Pharmaceutical Outsourcing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13768&type=smp
Browse Through More Reports Similar to the Global Advanced Therapeutics Pharmaceutical Outsourcing Market 2026, By The Business Research Company
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Pharmaceutical Fill And Finish Outsourcing Market Report 2026
Biologics Outsourcing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model